Raven Biotechnologies News
Most Popular Raven Biotechnologies Story
MacroGenics snags Raven Biotechnologies in buyout
Rockville, MA-based MacroGenics has struck a deal to buy Raven Biotechnologies, a South San Francisco-based developer of oncology drugs. MacroGenics said it plans to issue stock to complete the... Read more...
Latest Headlines
- July 17, 2008
- April 9, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
